Sponsors (8)
The bill expands federal support, clarification, and procurement preference for biobased products—boosting markets for farmers and small biobased manufacturers and encouraging lower lifecycle emissions—while raising the risk of higher procurement costs, compliance burdens, administrative load, and reduced transparency for the public.
Small biobased manufacturers and plant-based product makers (WHO) gain clearer eligibility, validated labeling, targeted outreach, and expanded federal procurement (WHAT), improving market access and potential sales to the federal government.
Farmers, foresters, and rural communities (WHO) gain new markets and increased demand for agricultural and forest commodities used in biobased products (WHAT), potentially raising farm incomes and supporting rural jobs.
USDA and federal program administration (WHO) are strengthened through clarified statutory definitions, expanded BioPreferred program authority, and better-coordinated R&D and labeling efforts (WHAT), reducing regulatory uncertainty and improving program implementation.
Taxpayers (WHO) may face higher federal procurement costs (WHAT) if mandated or preferential biobased purchases carry a price premium versus petroleum-based alternatives.
Small producers and manufacturers (WHO) could incur substantial compliance, certification, labeling, and verification costs (WHAT) to meet new definitions and lifecycle evidence requirements, which may be especially burdensome for small businesses and limit competition.
Reduced public transparency and oversight (WHO: taxpayers, public watchdogs) (WHAT) via a task force exemption from the Federal Advisory Committee Act, confidentiality rules for enforcement data, and allowance of non‑Federal contributions could limit public scrutiny and create perceptions of favoritism.
Based on analysis of 6 sections of legislative text.
Strengthens federal procurement, labeling, verification, training, and reporting requirements for biobased and plant‑based products and creates a USDA task force to expand markets.
Introduced August 1, 2025 by Mark Alford · Last progress August 1, 2025
Requires stronger federal purchasing, labeling, verification, training, and reporting for biobased and plant-based products; updates and expands statutory definitions for bioproducts and plant-based goods; creates a USDA Biobased Task Force to study and coordinate USDA programs and recommends program improvements; and makes it illegal to label or sell products using covered bioproduct terms unless they meet defined or Secretary-adopted definitions, with confidentiality protections for enforcement information. Direct effects include new annual targets for federal biobased purchases, agency training requirements, OFPP/USDA verification and public data collection, establishment of price-premium rules for biobased items, expanded reporting on unmet procurement, and a temporary USDA task force charged with mapping USDA activities and recommending ways to expand biobased markets and manufacturing.